The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease
Abstract
When exposed to a specific microenvironment, macrophages acquire either M1- or M2-polarized phenotypes associated with inflammation and tissue remodeling, respectively. Alveolar macrophages (AM) directly interact with environmental stimuli such as cigarette smoke, the major risk factor for chronic obstructive pulmonary disease (COPD), a disease characterized by lung inflammation and remodeling. Transcriptional profiling of AM obtained by bronchoalveolar lavage of 24 healthy nonsmokers, 34 healthy smokers, and 12 COPD smokers was performed to test the hypothesis whether smoking alters AM polarization, resulting in a disease-relevant activation phenotype. The analysis revealed that AM of healthy smokers exhibited a unique polarization pattern characterized by substantial suppression of M1-related inflammatory/immune genes and induction of genes associated with various M2-polarization programs relevant to tissue remodeling and immunoregulation. Such reciprocal changes progressed with the development of COPD, with M1-related gene expression being most dramatically down-regulated (p < 0.0001 vs healthy nonsmokers, p < 0.002 vs healthy smokers). Results were confirmed with TaqMan real-time PCR and flow cytometry. Among progressively down-regulated M1-related genes were those encoding type I chemokines CXCL9, CXCL10, CXCL11, and CCL5. Progressive activation of M2-related program was characterized by induction of tissue remodeling and immunoregulatory genes such as matrix metalloproteinase (MMP)2, MMP7, and adenosine A3 receptor (ADORA3). Principal component analysis revealed that differential expression of polarization-related genes has substantial contribution to global AM phenotypes associated with smoking and COPD. In summary, the data provide transcriptome-based evidence that AM likely contribute to COPD pathogenesis in a noninflammatory manner due to their smoking-induced reprogramming toward M1-deactivated, partially M2-polarized macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to previous literature (Shaykhiev et al., 2009), we did not see an enrichment of IL-4-IL-13-associated signatures in COPD patients with our data-driven approach”
From Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation (2014) · cites this paper as Shaykhiev et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982 · cited 1×
“Finally, there are several other cell types than AM in the lung capable of producing inflammatory mediators (9, 10, 39).”
BackgroundGrumelli, S., Corry, D. B., Song, L.-Z., Song, L., Green, L., Huh, J., Hacken, J., Espada, R., Bag, R., Lewis, D. E., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010008 · Cited by 484 · cited 13×
“Among these genes are those encoding type 1 chemokines CXCL11, CXCL9, CCL4, CCL5, inflammasome-related cytokines IL-1 and IL-18, costimulatory molecule CD80, complement-related proteins, a number of proteins involved in IFN- signaling.”
BackgroundInfluentialArginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells
Raes, G., Van den Bergh, R., De Baetselier, P., & Ghassabeh, G. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6561 · Cited by 302
Research works printed but not linked: 84
- 1999, Other functions, other genes: alternative activation of antigen-presenting cells., 137
- 1997, Pulmonary macrophages. R. G. Crystal, and J. B. West, and E. R. Weibel, and P. J. Barnes, eds., 859
- 1999, The macrophage in chronic obstructive pulmonary disease., S29
- 2007, Chronic obstructive pulmonary disease: a growing but neglected global epidemic., e112
- 2003, Chronic obstructive pulmonary disease: molecular and cellular mechanisms., 672
- 2008, Immunology of asthma and chronic obstructive pulmonary disease., 183
- 1995, Alveolar inflammation and its relation to emphysema in smokers., 1666
- 2004, The nature of small-airway obstruction in chronic obstructive pulmonary disease., 2645
- 2006, State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice., 494
- 2005, Role of CCR5 in IFN-γ-induced and cigarette smoke-induced emphysema., 3460
- 2007, CD8+ T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice., 8090
- 2005, A distinctive alveolar macrophage activation state induced by cigarette smoking., 1383
- 2006, Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking., 318
- 1997, Use of bronchoalveolar lavage and airway brushing to investigate the human lung. R. G. Crystal, and J. B. West, and E. R. Weibel, and P. J. Barnes, eds., 371
- 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing., 289
- 1988, Deactivation of macrophages by transforming growth factor-β., 260
- 1993, Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10., 713
- 1997, Cellular responses to interferon-γ., 749
- 1999, Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo., 1537
- 2002, Shaping gene expression in activated and resting primary macrophages by IL-10., 2253
- 2004, Interferon-γ: an overview of signals, mechanisms and functions., 163
- 2005, Polarized monocyte response to cytokine stimulation., R15
- 2005, Regulation of macrophage phenotype by long-term exposure to IL-10., 77
- 2006, Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression., 7303
- 2007, Transcriptional profiling of the LPS induced NF-κB response in macrophages., 1
- 2007, Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes., 1265
- 2008, Activation of a TGF-β-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-β receptor II., 6553
- 2002, Down-regulation of macrophage CD9 expression by interferon-gamma., 891
- 2002, Principal component analysis
- 2004, Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease., 27
- 2008, Functional phenotype of macrophages depends on assay procedures., 215
- 1993, Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes., 1358
- 2007, CCL23 expression is induced by IL-4 in a STAT6-dependent fashion., 4335
- 2002, Inflammation of the airways and lung parenchyma in COPD: role of T cells., 160S
- 2008, Molecular pathogenesis of emphysema., 394
- 1999, Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma., S21
- 2008, Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects., 450
- 1992, Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages., L471
- 1994, Altered cytokine regulation in the lungs of cigarette smokers., 696
- 2006, Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers., 428
- 2007, Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease., 748
- 2005, Respiratory tract infections: another reason not to smoke., 916
- 1988, Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers., 1309
- 2004, Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection., 1164
- 2008, Infection in the pathogenesis and course of chronic obstructive pulmonary disease., 2355
- 2001, Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease., 1618
- 2008, Respiratory viral infection in exacerbations of COPD., 1575
- 2008, Cigarette smoke selectively enhances viral PAMP- and virus-induced innate immune and remodeling responses in mice., 2771
- 2002, Effects of cigarette smoke on the immune system., 372
- 2001, Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine., 6518
- 2008, Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages., 27
- 1999, Effect of acrolein on human alveolar macrophage NF-κB activity., L550
- 2006, Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages., L46
- 2001, Cigarette smoking depletes cells spontaneously secreting Th1 cytokines in the human airway., 121
- 2007, CD4-regulatory cells in COPD patients., 156
- 2008, Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking., 555
- 2008, Regulatory T cells and immune tolerance., 775
- 1991, Macrophage deactivation by interleukin 10., 1549
- 2007, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism., 1757
- 2004, Tobacco smoking increases dramatically air concentrations of endotoxin., 421
- 2006, Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis., 233
- 2007, Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-κB in alveolar macrophages stimulated with TLR2 and TLR4 agonists., 6097
- 1996, Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators., 1019
- 1999, IL-10 up-regulates CCR5 gene expression in human monocytes., 241
- 2006, Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor., 133
- 2007, Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression., 1733
- 2000, Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema., 1081
- 2006, Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease., 474
- 2006, Developing COPD: a 25 year follow up study of the general population., 935
- 2006, Roger S. Mitchell lecture: chronic obstructive pulmonary disease phenotypes and their clinical relevance., 461
- 2008, The many “small COPDs”: COPD should be an orphan disease., 623
- 2008, Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages., 246
- 2008, A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis., 697
- 2000, Interferon γ induction of pulmonary emphysema in the adult urine lung., 1587
- 2005, Cigarette smoke-induced pulmonary emphysema in scid-mice: is the acquired immune system required?., 147
- 2008, CXCR3 and CCR5 chemokines in induced sputum from patients with COPD., 26
- 2002, Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease., 1404
- 2008, Peroxisome proliferator-activated receptor γactivation promotes infiltration of alternatively activated macrophages into adipose tissue., 22620
- 2006, Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-γ-dependent mechanism., e277
- 2008, Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo., 6270
- 2003, Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide., 4569
- 2006, Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC., 5825
- 2008, Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity., 5707
- 2001, Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3., 386
Cited by
Sorted by citations
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms
McGuinness, A., & Sapey, E. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020021 · Cited by 243
“Other research has described reduced M1 markers [79,80], and increased pro-inflammatory output [52,80].”
BackgroundToxic elements in tobacco and in cigarette smoke: inflammation and sensitization
Pappas, R. S. (2011) · Metallomics · doi:10.1039/c1mt00066g · Cited by 221
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
Wu, K., Byers, D. E., Jin, X., Agapov, E., Alexander-Brett, J., Patel, A. C., Cella, M., Gilfilan, S., Colonna, M., Kober, D. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141732 · Cited by 207
Metadata
- Authors
- Shaykhiev, R., Krause, A., Salit, J., Strulovici-Barel, Y., Harvey, B.-G., O'Connor, T. P., & Crystal, R. G.
- Affiliations
- Department of Genetic Medicine
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-08
- Volume
- 183
- Issue
- 4
- Pages
- 2867-2883
- ISSN
- 1550-6606
- 0022-1767
- PMC
- PMC2873685
- Cited by
- 359
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review